- Report
- May 2025
- 373 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 186 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 381 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 169 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 283 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 285 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 134 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 270 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 184 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 184 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 286 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 289 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 296 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 183 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 276 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 193 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 390 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 381 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 287 Pages
Global
From €5350EUR$5,850USD£4,554GBP
- Report
- May 2025
- 121 Pages
Global
From €5350EUR$5,850USD£4,554GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more
